Newscast: Regulatory 2025: Developing an effective 10-year strategy for technology-enabled regulatory transformation

May 11, 2018

Preparing to meet regulatory and commercial demands of the future requires a progressive, future-proof approach. As the regulatory department prepares for 2020 and the rest of the decade it must address transformative technologies that take it beyond increased productivity, compliance or TCO to also target improvements in innovation and decision-making and, ultimately, transform how the business works.

Watch this interview with David Scanlon, Sr. Director – Regulatory Strategy and Pratyusha Pallavi, Associate Director – Regulatory, to learn more about how LifeSphere® Regulatory multi-tenant cloud-based regulatory solution enables quick deployment, lower total cost of ownership (TCO), easy upgrades and inexpensive fine-tuning to facilitate quick reactions to changing regulations.

LATEST NEWS

About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global

Contact

Erika Thomas
ArisGlobal
+305-726-6601 | ethomas@arisglobal.com